Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
San Diego, Calif.-based medical device company CareFusion agrees to pay $41 million to end 2-year investigation into its marketing practices for ChloraPrep skin preparation product
A political action committee funded by employees of Abbott Laboratories reports that $16,000 in fraudulent checks were cashed against its bank account during the 1st quarter.
Haemonetics said it plans to cut 320 jobs as its shifts its manufacturing base to Mexico and Asia and posts lower profits for its fiscal 4th quarter and full year 2013.
An FDA advisory panel unanimously recommends against approval for Delcath’s liver cancer treatment, citing a too-high mortality rate, slashing nearly half the value from the company’s stock.
Medtronic warns on the potential for the wires on its deep-brain stimulation implants to be damaged during implantation.
Medical device tax opponent Sen. Amy Klobuchar (D-Minn.) says a repeal bill may be able to ride along on a larger corporate tax reform measure championed by Sen. Max Baucus (D-Mont.), largely considered the architect of the medtech levy.
Medical device sales representatives earned more on average than their peers in any other healthcare segment, including pharmaceuticals, according to a 2012 survey by MedReps.com.